Presbyterian/St. Luke's Medical Center is a hospital in the City Park West neighborhood of Denver. In speech and in writing, the hospital is referred to informally by its initials: P/SL.

There are 680 beds in Presbyterian - Saint Lukes Medical Center - Health One.

During the past decade, Presbyterian - Saint Lukes Medical Center - Health One conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 177 clinical trials were completed, i.e. on average, 155.3% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 74 clinical trials were completed. i.e. 224.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian - Saint Lukes Medical Center - Health One" #1 sponsor was "National Cancer Institute (NCI)" with 124 trials, followed by "Alliance for Clinical Trials in Oncology" with 67 trials sponsored, "SWOG Cancer Research Network" with 34 trials sponsored, "Children's Oncology Group" with 28 trials sponsored and "Eastern Cooperative Oncology Group" with 28 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian - Saint Lukes Medical Center - Health One" #1 collaborator was "National Cancer Institute (NCI)" with 208 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 11 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian - Saint Lukes Medical Center - Health One" are "Breast Cancer" (24 trials), "Leukemia" (18 trials), "Lymphoma" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials) and "Lung Cancer" (11 trials). Many other conditions were trialed in "Presbyterian - Saint Lukes Medical Center - Health One" in a lesser frequency.

Most popular intervention types in "Presbyterian - Saint Lukes Medical Center - Health One" are "Drug" (290 trials), "Other" (172 trials), "Biological" (152 trials), "Procedure" (76 trials) and "Radiation" (55 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (85 trials), "Quality-of-Life Assessment" (52 trials), "Paclitaxel" (32 trials), "placebo" (29 trials) and "Bevacizumab" (26 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian - Saint Lukes Medical Center - Health One" are 284 trials for "All" genders, 63 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Presbyterian - Saint Lukes Medical Center - Health One". undefined are not yet recruiting, 38 are recruiting, 107 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 175 completed trials in Presbyterian - Saint Lukes Medical Center - Health One, 4 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian - Saint Lukes Medical Center - Health One, 12 "Phase 1" clinical trials were conducted, 151 "Phase 2" clinical trials and 183 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".